# Intuniv vs Placebo in the Treatment of Childhood Intermittent Explosive Disorder

> **NCT02048241** · PHASE4 · COMPLETED · sponsor: **New York State Psychiatric Institute** · enrollment: 11 (actual)

## Conditions studied

- Intermittent Explosive Disorder
- Childhood Aggression
- Oppositional Defiant Disorder
- Attention Deficit Disorder

## Interventions

- **BEHAVIORAL:** Parent Management Training
- **OTHER:** Placebo
- **DRUG:** Intuniv

## Key facts

- **NCT ID:** NCT02048241
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2014-11
- **Final completion:** 2014-12
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2018-06-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02048241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02048241, "Intuniv vs Placebo in the Treatment of Childhood Intermittent Explosive Disorder". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02048241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*